JARMeC's profits surge 85% in nine months

Japan Animal Referral Medical Center (JARMeC) [TSE: 6039] announced its consolidated financial results for the nine months ended December 31, 2024, showing a robust performance compared to the same period last year. Net sales increased by 26.5% to ¥3.94 billion. Operating profit jumped 70.8% to ¥590 million, while ordinary profit rose 76.2% to ¥590 million. Profit attributable to owners of the parent company increased by 85.5% to ¥409 million. Earnings per share reached ¥157.86. The company forecasts full-year net sales of ¥5.22 billion, with operating and ordinary profit of ¥680 million, and profit attributable to owners of the parent at ¥475 million. The projected year-end dividend is ¥37 per share.